![ESHMPN2024 Highlight: Fascinating story by Adam Mead](https://oncodaily.com/pub/uploads/2024/04/GMGGNzdXQAAt43Y-1280x720.jpg)
ESHMPN2024 Highlight: Fascinating story by Adam Mead
The European School of Haematology (ESH), shared on X/Twitter insights from the 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024):
“Fascinating story (as always) by Professor Adam Mead, guiding us in the molecular pathogenesis to leukaemic transformation.”
Adam Mead is a Professor of Haematology at the University of Oxford. His research is focused on characterising genetic and cellular heterogeneity in myeloproliferative neoplasms (MPN).
Photo from Adam Mead/LinkedIn
The 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024)
The 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024) is held in Mandelieu-La Napoule, France, from April 26 to April 28.
The conference is co-chaired by Jean-Jacques Kiladjian, Ross Levine, and Jyoti Nangalia.
The European School of Haematology (ESH), established in 1985, is a non-profit organization dedicated to fostering education and sharing advanced knowledge in hematology and associated fields across Europe.
ESH offers both in-person and online training opportunities, and its conferences showcase the latest scientific advancements and research in hematology.
OncoDaily is a leading global media platform in oncology, committed to being the voice of oncology.